Log in

NASDAQ:CLSNCelsion Competitors & Alternatives

$2.78
-0.08 (-2.80 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.76
Now: $2.78
$2.93
50-Day Range
$1.12
MA: $1.75
$3.03
52-Week Range
$0.69
Now: $2.78
$3.65
Volume681,078 shs
Average Volume755,106 shs
Market Capitalization$81.33 million
P/E RatioN/A
Dividend YieldN/A
Beta2.45

Competitors

Celsion (NASDAQ:CLSN) Competitors and Alternatives

The following companies in the "pharmaceutical preparations" industry are considered alternatives and competitors to Celsion.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
Selecta Biosciences logo
SELB
Selecta Biosciences
2.2$3.79-5.0%$331.59 million$6.68 million-3.38
TherapeuticsMD logo
TXMD
TherapeuticsMD
1.5$1.18-5.1%$324.66 million$49.65 million-1.55Analyst Downgrade
OSMT
Osmotica Pharmaceuticals
1.1$6.68-5.8%$324.07 million$240.03 million-1.31
Geron logo
GERN
Geron
1.4$1.54-0.0%$321.24 million$460,000.00-3.95Analyst Upgrade
Rigel Pharmaceuticals logo
RIGL
Rigel Pharmaceuticals
1.5$1.89-1.1%$315.23 million$59.29 million-11.81
BCYC
Bicycle Therapeutics
1.0$17.40-0.4%$312.41 million$13.80 million-6.19
Ovid Therapeutics logo
OVID
Ovid Therapeutics
1.4$5.29-2.8%$311.53 millionN/A-3.55
Verrica Pharmaceuticals logo
VRCA
Verrica Pharmaceuticals
1.5$11.51-4.3%$309.77 millionN/A-9.43
OGI
OrganiGram
1.6$1.76-0.6%$307.48 million$61.27 million-8.80
MannKind logo
MNKD
MannKind
1.3$1.40-1.4%$303.72 million$63.04 million-6.09
Verastem logo
VSTM
Verastem
1.5$1.88-2.7%$301.49 million$17.46 million-1.02
Lannett logo
LCI
Lannett
1.6$7.93-6.7%$301.42 million$655.41 million-9.67
Avadel Pharmaceuticals logo
AVDL
Avadel Pharmaceuticals
1.5$8.07-0.6%$300.35 million$59.22 million-14.41
NEPT
Neptune Wellness Solutions
1.1$3.14-1.3%$299.44 million$18.39 million-10.47Upcoming Earnings
Heavy News Reporting
AMAG Pharmaceuticals logo
AMAG
AMAG Pharmaceuticals
1.6$8.89-2.9%$295.09 million$327.75 million-0.82
Menlo Therapeutics logo
MNLO
Menlo Therapeutics
1.5$2.06-7.3%$290.23 million$10.64 million-0.64High Trading Volume
Concert Pharmaceuticals logo
CNCE
Concert Pharmaceuticals
2.2$9.39-4.0%$274.89 million$1.08 million-3.07Analyst Downgrade
CymaBay Therapeutics logo
CBAY
CymaBay Therapeutics
1.7$3.82-0.8%$274.83 million$10 million-2.85Unusual Options Activity
Chiasma logo
CHMA
Chiasma
1.5$6.43-2.5%$264.97 millionN/A-5.85Analyst Downgrade
ProQR Therapeutics logo
PRQR
ProQR Therapeutics
1.4$5.30-0.4%$264.65 millionN/A-3.61
HOOK
Hookipa Pharma
1.2$11.56-1.0%$254.26 million$11.94 million-6.05
Spero Therapeutics logo
SPRO
Spero Therapeutics
1.6$12.44-2.5%$253.73 million$18.15 million-2.94Analyst Report
Affimed logo
AFMD
Affimed
1.6$3.48-4.9%$252.35 million$23.96 million-6.57Upcoming Earnings
Agile Therapeutics logo
AGRX
Agile Therapeutics
2.2$2.87-0.7%$248.55 millionN/A-7.97
Abeona Therapeutics logo
ABEO
Abeona Therapeutics
1.4$2.92-0.7%$246.59 million$3 million-1.76
REDHILL BIOPHAR/S logo
RDHL
REDHILL BIOPHAR/S
1.4$6.82-1.6%$244.42 million$6.29 million-4.64Analyst Downgrade
Obseva logo
OBSV
Obseva
1.5$4.79-5.6%$243.34 millionN/A-2.00Analyst Upgrade
Heavy News Reporting
OptiNose logo
OPTN
OptiNose
2.3$5.36-1.3%$242.86 million$34.63 million-2.09
Mallinckrodt logo
MNK
Mallinckrodt
2.0$2.81-1.4%$242.40 million$3.16 billion-0.20Heavy News Reporting
MediciNova logo
MNOV
MediciNova
1.8$5.33-2.8%$239.73 millionN/A0.00
GRTX
Galera Therapeutics
1.5$9.50-1.5%$239.31 millionN/A-0.58Heavy News Reporting
Fortress Biotech logo
FBIO
Fortress Biotech
1.3$2.97-2.7%$238.34 million$36.63 million-3.23
Marinus Pharmaceuticals logo
MRNS
Marinus Pharmaceuticals
1.5$2.75-2.9%$237.64 millionN/A-2.54
XOMA logo
XOMA
XOMA
2.1$21.75-0.8%$236.16 million$18.37 million-17.40
Ritter Pharmaceuticals logo
RTTR
Ritter Pharmaceuticals
0.5$0.45-1.8%$234.46 millionN/A-0.70Heavy News Reporting
NRBO
Iterum Therapeutics
0.8$13.73-2.7%$234.09 millionN/A-3.37Analyst Downgrade
High Trading Volume
Heavy News Reporting
LFVN
LifeVantage
0.9$15.89-4.4%$219.56 million$225.96 million20.11
Inflarx logo
IFRX
Inflarx
0.8$8.18-1.2%$210.93 millionN/A-3.70Analyst Downgrade
NuCana logo
NCNA
NuCana
1.4$6.34-2.7%$210.14 millionN/A-8.03
Gemphire Therapeutics logo
GEMP
Gemphire Therapeutics
0.5$14.10-1.1%$209.67 millionN/A0.00
Chimerix logo
CMRX
Chimerix
2.1$3.19-1.3%$208.09 million$12.52 million-1.73
Lexicon Pharmaceuticals logo
LXRX
Lexicon Pharmaceuticals
1.7$1.95-3.1%$208.06 million$322.07 million3.15
Kalvista Pharmaceuticals logo
KALV
Kalvista Pharmaceuticals
1.5$11.70-0.9%$207.01 million$16.13 million-6.65Analyst Upgrade
Paratek Pharmaceuticals logo
PRTK
Paratek Pharmaceuticals
1.5$4.91-4.9%$204.16 million$16.54 million-1.41
ISEE
IVERIC bio
1.4$4.07-2.5%$203.03 million$209.98 million-2.97
ARAV
Aravive
1.6$12.15-0.4%$194.59 million$4.75 million-6.46
Kindred Biosciences logo
KIN
Kindred Biosciences
1.7$4.70-1.5%$193.70 million$4.26 million-2.70Analyst Report
vTv Therapeutics logo
VTVT
vTv Therapeutics
1.8$2.84-1.1%$193.43 million$2.76 million-6.04
Aduro BioTech logo
ADRO
Aduro BioTech
1.5$2.36-8.9%$192.40 million$17.26 million-2.88Analyst Report
Unusual Options Activity
Analyst Revision
NATR
Nature's Sunshine Products
1.4$9.92-0.2%$191.81 million$362.21 million24.20
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.